Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Smoking Among Individuals With PTSD: A Phase II, Randomized Study of Varenicline and Cognitive Behavioral Therapy

NCT00937235 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00937235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00937235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Smoking Among Individuals With PTSD: A Phase II, Randomized Study of Varenicline and Cognitive Behavioral Therapy
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2015
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking, nicotine dependence, post-traumatic stress disorder, tobacco use disorder